Search Results - "Noutsias, M"

Refine Results
  1. 1

    Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction: A retrospective cohort study by De Vecchis, R., Ariano, C., Di Biase, G., Noutsias, M.

    Published in Herz (01-08-2019)
    “…Background The combination drug sacubitril/valsartan was reported to be superior to enalapril in reducing all-cause death, cardiovascular mortality, and heart…”
    Get full text
    Journal Article
  2. 2

    Cognitive performance of patients with chronic heart failure on sacubitril/valsartan: A retrospective cohort study by De Vecchis, R., Ariano, C., Di Biase, G., Noutsias, M.

    Published in Herz (01-09-2019)
    “…Background Sacubitril, a neprilysin inhibitor in the combination molecule sacubitril/valsartan, slows down degradation of endogenous natriuretic peptides,…”
    Get full text
    Journal Article
  3. 3

    Viral persistence in the myocardium is associated with progressive cardiac dysfunction by KÜHL, Uwe, PAUSCHINGER, Matthias, SEEBERG, Bettina, LASSNER, Dirk, NOUTSIAS, Michel, POLLER, Wolfgang, SCHULTHEISS, Heinz-Peter

    Published in Circulation (New York, N.Y.) (27-09-2005)
    “…Cardiotropic viral infections have been suspected as one possible cause of myocarditis and dilated cardiomyopathy. Although adverse outcomes in dilated…”
    Get full text
    Journal Article
  4. 4

    High prevalence of viral genomes and multiple viral infections in the myocardium of adults with idiopathic left ventricular dysfunction by KÜHL, Uwe, PAUSCHINGER, Matthias, NOUTSIAS, Michel, SEEBERG, Bettina, BOCK, Thomas, LASSNER, Dirk, POLLER, Wolfgang, KANDOLF, Reinhard, SCHULTHEISS, Heinz-Peter

    Published in Circulation (New York, N.Y.) (22-02-2005)
    “…For a long time, enteroviruses have been considered to be the most common cause of acute viral myocarditis (MC), with possible transition from MC to dilated…”
    Get full text
    Journal Article
  5. 5

    In HFREF patients, sacubitril/valsartan, given at relatively low doses, does not lead to increased mortality or hospitalization: A retrospective cohort study by De Vecchis, R., Ariano, C., Di Biase, G., Noutsias, M.

    Published in Herz (01-11-2019)
    “…Introduction In heart failure with reduced left ventricular ejection fraction (HFREF) patients, the dosage of sacubitril/valsartan is modulated according to…”
    Get full text
    Journal Article
  6. 6

    In-hospital mortality after acute STEMI in patients undergoing primary PCI by Ali, M., Lange, S. A., Wittlinger, T., Lehnert, G., Rigopoulos, A. G., Noutsias, M.

    Published in Herz (01-12-2018)
    “…Background Acute myocardial infarction (AMI) is the main cause of global and in-hospital mortality in patients with cardiovascular diseases. We aimed to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy by Van Linthout, S, Riad, A, Dhayat, N, Spillmann, F, Du, J, Dhayat, S, Westermann, D, Hilfiker-Kleiner, D, Noutsias, M, Laufs, U, Schultheiss, H.-P, Tschöpe, C

    Published in Diabetologia (01-09-2007)
    “…Aims/hypothesis Emerging evidence suggests that statins exert beneficial effects beyond those predicted by their cholesterol-lowering actions. We investigated…”
    Get full text
    Journal Article
  9. 9

    Transcatheter vs. surgical aortic valve replacement and medical treatment: Systematic review and meta-analysis of randomized and non-randomized trials by Ak, A., Porokhovnikov, I., Kuethe, F., Schulze, P. C., Noutsias, M., Schlattmann, P.

    Published in Herz (01-06-2018)
    “…Background Transcatheter aortic valve replacement (TAVR) has emerged as the procedure of choice for patients with severe aortic stenosis (AS) and high…”
    Get full text
    Journal Article
  10. 10

    Minimally invasive direct coronary bypass surgery via distal mini-sternotomy: Promising clinical results with anaortic, multivessel, all-arterial technique by Martinovic, I., Lindemann, S., Irqsusi, M., Mirat, J., Vcev, A., Wittlinger, T., Noutsias, M.

    Published in Herz (01-11-2019)
    “…Background Minimally invasive direct coronary artery bypass grafting (MIDCAB) was developed to decrease perioperative morbidity, some of which may be related…”
    Get full text
    Journal Article
  11. 11

    Efficacy of RADPAD protective drape during coronary angiography by Kherad, B., Jerichow, T., Blaschke, F., Noutsias, M., Pieske, B., Tschöpe, C., Krackhardt, F.

    Published in Herz (01-06-2018)
    “…Background Ionizing radiation is an integral part of percutaneous coronary angiographies. Chronic exposure to low-dose radiation confers a risk for skin…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support by Schlitt, A, Guha, M, Noutsias, M, Klein, H H, Klein, H U

    Published in Herz (01-08-2019)
    “…Assessment of a permanent risk of life-threatening ventricular arrhythmia in patients with severely reduced left ventricular ejection fraction (LVEF <35%), e…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Acute heart failure: An unmet medical need by Rigopoulos, A. G., Bakogiannis, C., de Vecchis, R., Sakellaropoulos, S., Ali, M., Teren, M., Matiakis, M., Tschoepe, C., Noutsias, M.

    Published in Herz (01-02-2019)
    “…Despite recent advances in the management of heart failure with reduced ejection fraction (HFrEF), the burden of acute heart failure (AHF) remains significant…”
    Get full text
    Journal Article
  18. 18

    Association between TLR2/TLR4 gene polymorphisms and COPD phenotype in a Greek cohort by Apostolou, A., Kerenidi, T., Michopoulos, A., Gourgoulianis, K. I., Noutsias, M., Germenis, A. E., Speletas, M.

    Published in Herz (01-12-2017)
    “…Background Considering that the innate immune system plays a pivotal role in the pathogenesis of chronic obstructive pulmonary disease (COPD), we hypothesized…”
    Get full text
    Journal Article
  19. 19

    High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction by TSCHÖPE, C, BOCK, C.-T, SCHULTHEISS, H.-P, KASNER, M, NOUTSIAS, M, WESTERMANN, D, SCHWIMMBECK, P.-L, PAUSCHINGER, M, POLLER, W.-C, KÜHL, U, KANDOLF, R

    Published in Circulation (New York, N.Y.) (22-02-2005)
    “…The etiology of left ventricular (LV) isolated diastolic dysfunction often remains unclear. In the present study, we report a strong association between…”
    Get full text
    Journal Article
  20. 20

    Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT) by Krackhardt, F., Waliszewski, M., Rischner, J., Piot, C., Pansieri, M., Ruiz-Poveda, F. L., Boxberger, M., Noutsias, M., Ríos, X. F., Kherad, B.

    Published in Herz (01-08-2019)
    “…Background Diabetes mellitus is known to be associated with worse clinical outcomes in patients with coronary artery disease (CAD) undergoing percutaneous…”
    Get full text
    Journal Article